Zydus Pharmaceuticals USA Inc. received FDA approval for its generic oral tablets of Lamotrigine under ANDA207763, a move that is expected to heighten competitive pricing and offer payers a lower-cost alternative to branded formulations.
Zydus Pharmaceuticals USA Inc. received FDA approval for its generic oral tablets of Lamotrigine under ANDA207763, a move that is expected to heighten competitive pricing and offer payers a lower-cost alternative to branded formulations.